(Q35758264)

10 August 2017

1 reference

title

Radioresistant laryngeal cancer: beyond the TNM stage (English)

1 reference

10 August 2017

1 reference

Nix PA

1

1 reference

10 August 2017

Greenman J

series ordinal

2

1 reference

10 August 2017

Cawkwell L

series ordinal

3

1 reference

10 August 2017

Stafford N

series ordinal

4

1 reference

10 August 2017

publication date

1 April 2004

1 reference

10 August 2017

published in

Clinical Otolaryngology

1 reference

10 August 2017

volume

29

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

105-114

1 reference

Carcinoma of the subglottic larynx

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

A critical review of radiotherapy in the management of T1 glottic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Prognostic factors of local control after radiotherapy in T1 glottic and supraglottic carcinoma of the larynx.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Glottic carcinoma--patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Markers in cancer of the larynx and pharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Primary radiotherapy of carcinoma of the supraglottic larynx--a multivariate analysis of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Predicting radioresistance in early glottic squamous cell carcinoma by DNA content

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Significance of DNA Ploidy in the Treatment of T1 Glottic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Genome-wide screening for radiation response factors in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Angiogenesis in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Low vascular density indicates poor response to radiotherapy in small glottic carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

MIB-1 and p53 expression in radiotherapy-resistant T1aN0M0 glottic squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Overexpression of Bcl-2 in squamous cell carcinoma of the larynx: a marker of radioresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

The role of p53 in determining sensitivity to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

The dynamics of cyclin dependent kinase structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Mechanisms of apoptosis avoidance in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Apoptosis and the response to anticancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Apoptotic markers for tumor recurrence: a minireview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Microarray and histopathological analysis of tumours: the future and the past?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

Results of radiotherapy for primary subglottic squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00796.X

10.1046/J.1365-2273.2003.00796.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference